Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02630420
Title Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Yale University

head and neck squamous cell carcinoma

colorectal cancer


Cetuximab + Savolitinib

Age Groups: adult
Covered Countries

Additional content available in CKB BOOST